LINC02884

Across TCGA pan-cancer cohorts, LINC02884 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC02884 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher LINC02884 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated LINC02884 expression acts as an unfavorable survival marker, although some lineages such as MESO and LIHC show a favorable association.

MESO, LIHC, and BRCA are the cancer types where LINC02884 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Quartile	III,IV	0.531	0.255	<.001	84	view →
LIHC	DFS	Median	II,III,IV	0.533	0.327	<.001	58	view →
BRCA	OS	Tertile	All	0.985	0.949	<.001	57	view →
STAD	OS	Median	All	0.412	0.654	.004	28	view →
SKCM	OS	Tertile	IV	0.867	0.244	.006	28	view →
UCS	DFS	Tertile	III,IV	0.519	0.101	.011	24	view →
LGG	DFS	Quartile	All	0.624	0.858	<.001	22	view →
BLCA	OS	Tertile	II,III,IV	0.317	0.576	.006	20	view →
CHOL	DFS	Tertile	All	0.725	0.204	.001	19	view →
SARC	OS	Median	All	0.834	0.616	<.001	19	view →
ACC	OS	Tertile	All	0.795	0.952	.013	19	view →
KIRC	DFS	Quartile	IV	0.701	0.348	.024	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC02884–MESO (DFS)

Open the MESO breakdown →